As of 2025-10-22, the Relative Valuation of Seres Therapeutics Inc (MCRB) is 18.75 USD. This relative valuation is based on P/E multiples. With the latest stock price at 18.75 USD, the upside of Seres Therapeutics Inc based on Relative Valuation is -0.0%.
The range of the Relative Valuation is 18.75 - 18.75 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 1171.5x - 1171.5x | 1171.5x |
| Fair Price | 18.75 - 18.75 | 18.75 |
| Upside | -0.0% - -0.0% | -0.0% |
| Date | P/E |